LDHB and pancreatic neoplasm: It has been proposed that pancreatic cancer [46] and breast cancer [47] patients with lower LDHB expression are more likely to show positive responses to treatment, and LDHB has frequently been proposed as a diagnostic and prognostic marker in prostate cancer [48,49].